Ph.D., BSc, President, Tynan Consulting LLC
Dr Tynan has 20+ years of entrepreneurship in the life science and healthcare industries. She is known for her work on clinical diagnostics innovation, strategy and working with multiple health industry stakeholders to understand and solve complex problems. She has worked on the commercialization of health-related products and services; Market Access; Health Economics; and has the ability to simplify complex clinical practices to optimize product positioning and value articulation.
Session Abstract – PMWC 2018 Silicon Valley
Session Synopsis: A tremendous amount of work and effort is put into FDA approval of a drug, yet often the necessary accompanying diagnostics are not in place to meet the needs in a timely fashion. Upstream processes, such as tighter collaborations between pharma and diagnostics companies, more robust and earlier assay development, better transition of translational insight into clinical applications, or clinical trial design itself need to be optimized. This session’s dialogue will focus on these aspects and how a critical diagnostics component can be optimally integrated into a commercial strategy to create a more efficient and successful approval and commercialization process.